Hepatitis C Virus (HCV) NS3 Sequence Diversity and Antiviral Resistance-Associated Variant Frequency in HCV/HIV Coinfection

HIV coinfection accelerates disease progression in chronic hepatitis C and reduces sustained antiviral responses (SVR) to interferon-based therapy. New direct-acting antivirals (DAAs) promise higher SVR rates, but the selection of preexisting resistance-associated variants (RAVs) may lead to virolog...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Jabara, Cassandra B., Hu, Fengyu, Mollan, Katie R., Williford, Sara E., Menezes, Prema, Yang, Yan, Eron, Joseph J., Fried, Michael W., Hudgens, Michael G., Jones, Corbin D., Swanstrom, Ronald, Lemon, Stanley M.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: American Society for Microbiology 2014
Gaiak:
Antiviral Agents
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC4187920/
https://ncbi.nlm.nih.gov/pubmed/25092699
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.03466-14
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak